Wnt7a-Fzd7 signalling directly activates the Akt/mTOR anabolic growth pathway in skeletal muscle

Nature Cell Biology

Volumn 14, Issue 2, 2012, Pages 186-191

  Von Maltzahn, Julia ^a   Bentzinger, C Florian ^a   Rudnicki, Michael A ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FRIZZLED PROTEIN; FZD7 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN RECEPTOR; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; WNT7A PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL POLARITY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE HYPERTROPHY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; STEM CELL; TISSUE REPAIR;

ANIMALS; CELL LINE; CELLS, CULTURED; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUMINESCENT PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; WNT PROTEINS;

EID: 84856500662     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2404     Document Type: Article

References (40)

1. Gordon, M. D. & Nusse, R. Wnt signalling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem. 281, 22429-22433 (2006).
2. Wodarz, A. & Nusse, R. Mechanisms of Wnt signalling in development. Annu. Rev. Cell Dev. Biol. 14, 59-88 (1998).
3. Montcouquiol, M. & Kelley, M. W. Planar and vertical signals control cellular differentiation and patterning in the mammalian cochlea. J. Neurosci. 23, 9469-9478 (2003). (Pubitemid 37323049)
4. Le Grand, F., Jones, A. E., Seale, V., Scime, A. & Rudnicki, M. A. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell 4, 535-547 (2009).
5. Tajbakhsh, S. et al. Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf5. Development 125, 4155-4162 (1998). (Pubitemid 28528923)
6. Chen, A. E., Ginty, D. D. & Fan, C. M. Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433, 317-322 (2005).
7. Borello, U. et al. The Wnt/β-catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis. Development 133, 3723-3732 (2006). (Pubitemid 44614293)
8. Anakwe, K. et al. Wnt signalling regulates myogenic differentiation in the developing avian wing. Development 130, 3503-3514 (2003). (Pubitemid 37010013)
9. Rochat, A. et al. Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy. Mol. Biol. cell 15, 4544-4555 (2004). (Pubitemid 39299103)
10. van der Velden, J. L. et al. Inhibition of glycogen synthase kinase-3βactivity is suficient to stimulate myogenic differentiation. Am. J. Physiol. 290, C453-C462 (2006).
11. Brack, A. S., Conboy, I. M., Conboy, M. J., Shen, J. & Rando, T. A. A temporal switch from notch to Wnt signalling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2, 50-59 (2008).
12. Kuang, S., Kuroda, K., Le Grand, F. & Rudnicki, M. A. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129, 999-1010 (2007). (Pubitemid 46802699)
13. Glass, D. J. Skeletal muscle hypertrophy and atrophy signalling pathways. Int. J. Biochem. Cell Biol. 37, 1974-1984 (2005). (Pubitemid 41206815)
14. Crescenzi, M., Crouch, D. H. & Tato, F. Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells. J. Cell Biol. 125, 1137-1145 (1994). (Pubitemid 24177215)
15. Collins, A. R., Squires, S. & Johnson, R. T. Inhibitors of repair DNA synthesis. Nucleic Acids Res. 10, 1203-1213 (1982).
16. Tanaka, S., Akiyoshi, T., Mori, M., Wands, J. R. & Sugimachi, K. A novel frizzled gene identified in human esophageal carcinoma mediates APC/β-catenin signals. Proc. Natl Acad. Sci. USA 95, 10164-10169 (1998). (Pubitemid 28415312)
17. Kengaku, M. et al. Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science 280, 1274-1277 (1998). (Pubitemid 128667609)
18. Harwood, A.J. Regulation of GSK-3: a cellular multiprocessor. Cell 105, 821-824 (2001). (Pubitemid 32635083)
19. Parrizas, M., Gazit, A., Levitzki, A., Wertheimer, E. & LeRoith, D. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 138, 1427-1433 (1997). (Pubitemid 27137089)
20. Kandarian, S. C. & Jackman, R. W. Intracellular signalling during skeletal muscle atrophy. Muscle Nerve 33, 155-165 (2006). (Pubitemid 43208671)
21. Miyazaki, M. & Esser, K. A. Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals. J. Appl. Physiol. 106, 1367-1373 (2009).
22. Pietrangelo, T. et al. Characterization of specific GTP binding sites in C2C12 mouse skeletal muscle cells. J. Muscle Res. Cell Motil. 23, 107-118 (2002). (Pubitemid 35192110)
23. Freissmuth, M. et al. Suramin analogues as subtype-selective G protein inhibitors. Mol. Pharmacol. 49, 602-611 (1996). (Pubitemid 26117644)
24. Schulte, G. & Bryja, V. The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol. Sci. 28, 518-525 (2007). (Pubitemid 47488504)
25. Foord, S. M. et al. International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol. Rev. 57, 279-288 (2005). (Pubitemid 41043887)
26. Timmers, S., Schrauwen, P. & de Vogel, J. Muscular diacylglycerol metabolism and insulin resistance. Physiol. Behav. 94, 242-251 (2008). (Pubitemid 351615425)
27. Frost, R. A. & Lang, C. H. Protein kinase B/Akt: a nexus of growth factor and cytokine signalling in determining muscle mass. J. Appl. Physiol. 103, 378-387 (2007). (Pubitemid 47092315)
28. Tisdale, M. J. Cancer cachexia. Curr. Opin. Gastroenterol. 26, 146-151 (2010).
29. Sakuma, K. & Yamaguchi, A. Molecular mechanisms in aging and current strategies to counteract sarcopenia. Curr. Aging Sci. 3, 90-101 (2010).
30. Costelli, P. et al. IGF-1 is downregulated in experimental cancer cachexia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R674-R683 (2006). (Pubitemid 44352350)
31. Botfield, C., Ross, R. J. & Hinds, C. J. The role of IGFs in catabolism. Baillieres Clin. Endocrinol. Metab. 11, 679-697 (1997). (Pubitemid 28200845)
32. Lang, C. H., Hong-Brown, L. & Frost, R. A. Cytokine inhibition of JAK-STAT signalling: a new mechanism of growth hormone resistance. Pediatr. Nephrol. 20, 306-312 (2005). (Pubitemid 40309934)
33. Grounds, M. D., Radley, H. G., Gebski, B. L., Bogoyevitch, M. A. & Shavlakadze, T. Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle. Clin. Exp. Pharmacol. Physiol. 35, 846-851 (2008). (Pubitemid 351725233)
34. Del Aguila, L. F. et al. Muscle damage impairs insulin stimulation of IRS-1, PI 3-kinase, and Akt-kinase in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 279, E206-E212 (2000). (Pubitemid 30609963)
35. de Alvaro, C., Teruel, T., Hernandez, R. & Lorenzo, M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitorκB kinase in a p38 MAPK-dependent manner. J. Biol. Chem. 279, 17070-17078 (2004). (Pubitemid 38560462)
36. Megeney, L. A., Kablar, B., Garrett, K., Anderson, J. E. & Rudnicki, M. A. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10, 1173-1183 (1996). (Pubitemid 26171100)
37. von Maltzahn, J., Euwens, C., Willecke, K. & Sohl, G. The novel mouse connexin39 gene is expressed in developing striated muscle fibers. J. Cell Sci. 117, 5381-5392 (2004). (Pubitemid 39562499)
38. Parker, M. H., Perry, R. L., Fauteux, M. C., Berkes, C. A. & Rudnicki, M. A. MyoD synergizes with the E-protein HEB beta to induce myogenic differentiation. Mol. Cell. Biol. 26, 5771-5783 (2006). (Pubitemid 44134333)
39. Gillespie, M. A. et al. p38-f g-dependent gene silencing restricts entry into the myogenic differentiation program. J. Cell Biol. 187, 991-1005 (2009).
40. McKinnell, I. W. et al. Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nat. Cell Biol. 10, 77-84 (2008).